Abstract:Objective To investigate the changes and significance of plasma level of homocysteine (Hcy) in Parkinson disease (PD) patients with cognitive dysfunction. Methods Ninety-two PD patients were enrolled. Among them, 51 patients had mild cognitive impairment (CI), and the other 41 had not CI. Forty healthy subjects were enrolled as control group. The information including gender, age, illness duration, years of education and Hoehn and Yahr (H-Y) stage were recorded. Cognitive function of all the patients with PD and the controls were measured by using Montreal Cognitive Assessment (MoCA) scale. Plasma levels of Hcy, folic acid and vitamin B12 were measured by high performance liquid chromatography or radioimmunoassay. Results The plasma level of Hcy in PD group was significantly higher than that in control group: (16.72 ± 5.52) μmol/L vs. (13.65 ± 5.16) μmol/L, there was statistical difference (P<0.05). The plasma level of Hcy in patients with CI was (18.13 ± 4.67)μmol/L, and the patients without CI was (15.44 ± 3.71) μmol/L, the plasma levels of Hcy in patients with CI and without CI were significantly higher than that in control group, furthermore the plasma level of Hcy in patients with CI was significantly higher than that in patients without CI, there were statistical differences (P<0.05). The plasma level of folic acid in PD group was significantly lower than that in control group:(7.15 ± 3.54) μg/L vs. (8.73 ± 3.78) μg/L, there was statistical difference (P<0.05). The plasma level of folic acid in patients with CI was (7.11 ± 3.95) μg/L, and the patients without CI was (7.36 ± 3.84) μg/L, the plasma levels of folic acid in patients with CI and without CI were significantly lower than that in control group, there were statistical differences (P<0.05). But there was no statistical difference in the plasma of folic acid between patients with CI and patients without CI (P>0.05). There was no statistical difference in the plasma of vitamin B12 between the 2 groups (P>0.05). There was a negative relationship between plasma levels of Hcy and folic acid (r =-0.576, P<0.01). The plasma level of Hcy in early PD patients was significantly lower than that in middle-late patients:(15.14 ± 5.31)μmol/L vs. (17.75 ± 5.87) μmol/L, there was statistical difference (P<0.05), and there were no statistical differences in the plasma levels of folic acid and vitamin B12 between early PD patients and middle-late patients (P>0.05). The correlation analysis results showed that MoCA score was positive correlation with years of education (β = 0.541, P = 0.000), MoCA score was negative correlation with illness duration, H-Y stag and plasma level of Hcy (β=-0.417, -0.367 and-0.515;P=0.026, 0.037 and 0.000), but MoCA score was not correlation with age, plasma levels of folic acid and vitamin B12 (P>0.05). Conclusions The changes of plasma level of Hcy may be involved in the pathogenesis of patients with PD. The elevated plasma level of Hcy is significantly correlated with CI, it is an important risk factors of CI in patients with PD.

Relation between plasma homocysteine and cognitive impairment of patients with alcohol dependence

[Relationship Between Plasma Total Homocysteine and Mild Cognitive Impairment in Senile Patients with Type 2 Diabetes].

Study on Plasma Brain-Derived Neurotrophic Factor Levels in the Cognitive of Patients with Alcohol Dependence

Effect of Plasma Homocysteine Levels and Mild Cognitive Dysfunction on Elderly Type 2 Diabetes

Meta-Analysis of Plasma Homocysteine Content and Cognitive Function in Elderly Patients with Alzheimer'S Disease and Vascular Dementia

[Investigation on Plasma Homocysteine Level and Cognition in Population at High Risk for Stroke in Xi'an].

Relationship between plasma homocysteine and alcoholic liver cirrhosis

The changes and significance of plasma level of homocysteine in Parkinson disease patients with cognitive function

Research about the relationship between homocysteine and vascular cognitive impairment

Relationship between High Homocysteine Levels in Serum and Cognitive Impairment of Patients with Parkinson′ s Disease

Study on the Correlation between Blood Homocysteine Level and Cognitive Function in Patients with Cerebrovascular Disease

Association between plasma homocysteine levels and cognitive deficits in Han Chinese patients with schizophrenia across age groups

Correlation between plasma homocysteine and cognitive function in patients with tardive dyskinesia

Homocysteine Altered Gyrification Related to Self‐awareness of Everyday Cognition

Cerebral small vessel disease mediates the association between homocysteine and cognitive function

ReLationship between serum Leptin LeveLs and the cognitive functions of aLcohoL dependent patients

Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: Moderated by brain cortical thickness

Plasma homocysteine and longitudinal change in cognitive function among urban adults

Threshold effect of plasma total homocysteine levels on cognitive function among hypertensive patients in China: A cross-sectional study

Homocysteine levels and cognitive function scores measured with MMSE and BCAT of middle-aged and elderly subjects in Tianjin City

Association of homocysteine with plasma amyloid β protein in aging and neurodegenerative disease